Welcome to the Moderna fourth quarter 2024 conference call. At this time, all participants are in a listen-only mode. After ...
The company delivered a loss of $2.91 per share, worse than the expected loss of $2.68 per share. Moderna is a biotechnology company primarily engaged in the development and manufacturing of messenger ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results